Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune response, offering new potential for immunotherapy. Dana-Farber researchers have discovered that in ...

GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective ...

Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...

All had been diagnosed with clear cell renal cell carcinoma (ccRCC) – the most common type of kidney cancer – which had not ...

Objective: To assess the feasibility of utilizing parameters derived from a multimodal apparent diffusion (MAD) model to distinguish between low- and high-grade clear cell renal cell carcinoma (ccRCC) ...

Listen to Story India's first Car-T cell therapy showed 73% response rate This therapy is used to for the treatment of blood cancers It modifies the body's immune cells to kill cancer cells After over ...

The study will evaluate the investigational drug product ONC175 (orellanine) in patients with metastatic clear cell or papillary renal cell carcinoma. The FDA has accepted an investigational new drug ...

If you are diagnosed with metastatic kidney cancer -- cancer that has spread beyond your kidney -- immunotherapy may help you live longer. This type of treatment helps your immune system find and ...

1Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. 2Center for Precision and Environmental Health, Baylor College of Medicine, Houston, Texas. 3Department of ...